Allen Biotechnology Co ABC
Retatrutide
Finnrick tested 3 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Allen Biotechnology Co ABC between 4 Aug 2025 and 10 Sep 2025. Test scores average over 6, no score below 5, and at least 2 tests warrant a tentative Finnrick Rating of B (Good).
Finnrick Rating™
Tentative Rating
Allen Biotechnology Co ABC
Retatrutide
Tested 3 Samples
Last test 10 Sep 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Allen Biotechnology Co ABC
Samples are tested in commercial labs
Tests Count
3
Scores
AVGMINMAX
Last
10 Sep 2025
First
4 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 10 Sep 2025 | View | 10mg | 9.750mg | -2.5% | 99.81% | (no batch ID) | White Label / Silver Crimp / White Cap | Lab E | Public | |
| 21 Aug 2025 | View | 10mg | 11.400mg | +14.0% | 99.82% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab E | Public | |
| 4 Aug 2025 | View | 20mg | 20.900mg | +4.5% | 99.84% | (no batch ID) | No Label / Silver Crimp / Blue Cap | Lab E | Public | |